National Academies Press: OpenBook
Suggested Citation:"Front Matter." National Academies of Sciences, Engineering, and Medicine. 2020. Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. doi: 10.17226/25914.
×
Page 1
Suggested Citation:"Front Matter." National Academies of Sciences, Engineering, and Medicine. 2020. Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. doi: 10.17226/25914.
×
Page 2

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine Committee on Equitable Allocation of Vaccine for the Novel Coronavirus DISCLAIMER: This discussion draft is not intended to be the final framework recommended by the committee, and the information contained herein is subject to change based on public comments and further committee deliberations. The committee’s final report and recommended framework is forthcoming. The public comment period will be available from 12:00 p.m. ET on Tuesday, September 1, 2020, until 11:59 p.m. ET on Friday, September 4, 2020. For additional information on how to submit comments, please visit https://www.nationalacademies.org/VaccineAllocationComment Copyright 2020 by the National Academy of Sciences. All rights reserved. DISCUSSION DRAFT FOR PUBLIC COMMENT

BACKGROUND As part of the overall study, the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus is releasing a discussion draft of its framework for public comment. This discussion draft outlines a preliminary framework for equitable allocation of COVID-19 vaccine. Please note that this is a discussion draft of only the framework. Other aspects of the Statement of Task, including risk communication, steps to mitigate vaccine hesitancy, and global considerations will be addressed in the final report. STATEMENT OF TASK An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will develop an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities in planning for equitable allocation of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The expectation is that such a framework would inform the decisions by health authorities, including the Advisory Committee on Immunization Practices (ACIP), as they create and implement national and/or local guidelines for SARS-CoV-2 vaccine allocation. As part of this effort, the committee will consider the following: • What criteria should be used in setting priorities for equitable allocation of vaccine? • How should the criteria be applied in determining the first tier of vaccine recipients? As more vaccine becomes available, what populations should be added successively to the priority list of recipients? How do we take into account factors such as: o Health disparities and other health access issues o Individuals at higher risk (e.g., elderly, underlying health conditions) o Occupations at higher risk (e.g., health care workers, essential industries, meat packing plants, military) o Populations at higher risk (e.g., racial and ethnic groups, incarcerated individuals, residents of nursing homes, individuals who are homeless) o Geographic distribution of active virus spread o Countries/populations involved in clinical trials • How will the framework apply in various scenarios (e.g., different characteristics of vaccines and differing available doses)? • If multiple vaccine candidates are available, how should we ensure equity? • How can countries ensure equity in allocation of COVID-19 vaccines? • For the United States, how can communities of color be assured access to vaccination? • How can we communicate to the American public about vaccine allocation to minimize perceptions of lack of equity? • What steps should be taken to mitigate vaccine hesitancy, especially among high- priority populations? COMMITTEE SPONSORS Centers for Disease Control and Prevention and National Institutes of Health and DISCUSSION DRAFT FOR PUBLIC COMMENT 2

Next: A Note from the Committee Co-Chairs »
Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

On September 1, 2020, the National Academies of Sciences, Engineering, and Medicine invited public comment on the Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, commissioned by the Centers for Disease Control and the National Institutes of Health. Input from the public, especially communities disproportionately affected by the COVID-19 pandemic, is essential to produce a final report that is objective, balanced, and inclusive. The public comment period was open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4.

In addition, the study committee hosted a listening session on Wednesday, September 2, from 12:00 to 5:00 p.m. ET to hear comments from the public. For more information, please visit the study webpage. If you have any questions, please email COVIDVaccineFramework@nas.edu.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!